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Abstract: Blood, a complex biological fluid, comprises 45% cellular components 
suspended in protein rich plasma. These different hematologic components perform 
distinct functions in vivo and thus the ability to efficiently fractionate blood into its 
individual components has innumerable applications in both clinical diagnosis and 
biological research. Yet, processing blood is not trivial. In the past decade, a flurry of 
new microfluidic based technologies has emerged to address this compelling problem. 
Microfluidics is an attractive solution for this application leveraging its numerous 
advantages to process clinical blood samples. This paper reviews the various microfluidic 
approaches realized to successfully fractionate one or more blood components. 
Techniques to separate plasma from hematologic cellular components as well as isolating 
blood cells of interest including certain rare cells are discussed. Comparisons based on 
common separation metrics including efficiency (sensitivity), purity (selectivity), and 
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throughput will be presented. Finally, we will provide insights into the challenges associated 
with blood-based separation systems towards realizing true point-of-care (POC) devices and 
provide future perspectives. 
Keywords: blood separation; microfluidics; cell separation; enrichment; disease detection 
and diagnosis 
 
1. Introduction  
Blood, perhaps the most important biological fluid, performs many fundamental functions to 
maintain homeostasis; from transporting nutrients and oxygen to tissues and organs to regulating pH 
and temperature. It also provides an efficient transit system through the vascular network for transport 
of immune cells for defense against foreign microbes and wound healing. As blood contains a myriad 
of information about the functioning of the human body, complete blood analysis has been a primary 
diagnostic test in our healthcare system. Broadly, plasma and cells constitute the two main blood 
components each with ~60% and 40% volume fractions respectively. The blood cellular components 
mainly consist of red blood cells (RBCs), leukocytes and platelets. Other rare-cells including fetal cells 
during pregnancy and epithelial tumor cells in cancer patients may also be found circulating in blood. 
Of the ~5 billion cells per milliliter of blood, red blood cells (RBCs) make up >99% of all cellular 
components. Due to the vast majority of RBCs, fractionating the various target components from blood 
has been a challenging problem both from a medical and engineering perspective. 
Conventional plasma and leukocyte separation methods have relied on membrane-based filtration. 
However, the high cellular fractions lead to membrane clogging and compromise separation efficiency. 
To address this, enormous progress has been made in the past few years in the area of microfluidics 
based blood component separations. Microfluidics is the science of studying fluid flow behavior at the 
microscale and the development of miniaturized analysis systems that take advantage of the unique 
physics emergent at these small scales [1,2]. Microfluidics leverages its many distinct advantages such 
as low sample volume for processing blood, as these samples are precious and rare especially in the 
case of neonatal care. A comprehensive review of processing blood on a microchip discussing the 
various sample preparation challenges, cell separation methods and integrated blood analysis modules 
was presented by Toner and Irimia [3]. However, the field of microfluidics based blood fractionation 
has significantly advanced since then and a review of the various microfluidic approaches developed in 
the past few years is warranted. 
In this paper we review recent microfluidic methods realized to successfully fractionate one or more 
blood components. Although microfluidic based cell separation techniques have been extensively 
reviewed in the past, to our knowledge this is the first attempt to summarize microfluidics based 
techniques to separate the individual blood components [4-9]. Detailed description of the various 
separation principles for each component will be discussed and comparisons based on separation 
metrics including efficiency (sensitivity), purity (selectivity), and throughput will be drawn. The 
readers are encouraged to read the original papers for additional details. Analysis of these individual 
components for clinical diagnosis or fundamental studies is beyond the scope of this review. 
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2. Plasma Separation 
Many clinical tests and research assays frequently require the removal of blood cells from plasma 
for downstream analysis and diagnosis. A simple diagnostic test of blood plasma for biological 
substances such as cholesterol, glucose and lactate can be used to evaluate the general state of health of 
various internal organs. The quantification of individual plasma proteins is also routine and important 
for diagnosis and monitoring of many diseases including paraproteinaemias, hemoglobinopathies, and 
genetic abnormalities [10,11]. However, it is critical to remove the large volume of interfering blood 
cells from whole blood so that the purified plasma can be assessed and diagnosed accurately. 
Traditionally, plasma is extracted from blood in laboratories and clinics by centrifugation with 
conventional bench-top centrifuges which are known to be expensive, time consuming and labor 
intensive. The practice of centrifugation has also been realized on the microscale using compact  
disk-like platforms with manifolds and a spinning motor plate to achieve centrifugal pumping, fostered 
by the need to develop an integrated total analysis system [12,13]. Haeberle and coworkers designed a 
decanting structure on a rotating disk for the extraction of plasma [12]. The technique efficiently extracts 
2 µL plasma from a 5 µL blood sample rotated at 40 Hz frequency within 20 s. The extracted plasma 
contained <0.11% blood cell concentration independent of rotation frequency. Recently, an innovative 
method to isolate plasma for resource limited settings has been demonstrated by Wong et al. using an 
egg beater as a hand-powered centrifuge [Figure 1(A)] [14]. By spinning the paddle, human whole blood 
loaded into polyethylene (PE) tubing attached to the end of the paddle of the egg beater is centrifuged. 
The blood cells settle down at the distal end of the PE tubing while plasma extracted from the 
supernatant can be used to perform diagnostic assays. The technique extracts ~58 µL plasma from 
100 μL whole blood after 8 min of centrifugation with very high purity (cell concentration 
~5 × 104 mL−1). However, during centrifugation the sedimented blood cells can easily lyse (RBCs 
hemolysis), thereby releasing intracellular components which contaminate the plasma sample [14]. To 
overcome this limitation, several microfluidic techniques for plasma isolation from blood have been 
recently reported. 
Perhaps the most common way of separating plasma from blood cells using microfluidic devices is 
based on the principle of particle retention. These devices frequently involve the use of micromachined 
filters or meshes to retard or block blood cell movement, thereby allowing the collection of the plasma 
portion of blood. In particular, comb and weir-type filter structures with well defined geometries have 
been designed and demonstrated [15-17]. Designing weirs with a gap size of 0.5 µm, VanDelinder and 
Groisman reported a cross-flow based microfluidic device for continuous plasma separation [16]. The 
0.5 µm gap permits the flow of plasma while impeding the RBCs, leukocytes and platelets. The device 
is capable of operating continuously for an hour extracting ~8% plasma at 0.65 µL/min throughput and 
<0.1% hemolysis. Similar design employing 0.5 µm gap transverse-flow microfilters was also reported 
by Crowley and Pizziconi [17]. Size-exclusion based techniques relying on integrated microporous 
fleece or membranes have also been developed [18,19]. Moorthy and Beebe fabricated porous filters 
inside a microchannel using emulsion photo-polymerization with the porosity of the filter being a 
function of the pre-polymer mixture constituting 2-hydroxyethyl methacrylate (HEMA, monomer), 
ethylene glycol dimethacrylate (EGDMA, cross-linker), and 2,2-dimethoxy-2-phenyl-acetophenone 
(DMPA, photo-initiator) in water. The device was tested with diluted blood (1:20) to demonstrate 
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separation. However, both the weir-based and membrane-based devices frequently suffer from RBCs 
contamination due to their extremely high deformability. This also poses enormous challenge to the 
fabrication as very small pore size or filters on the order of 1 μm or less are required to retain the 
RBCs effectively. Moreover, as the geometrical features of these devices become smaller, clogging 
becomes a major concern and blood has to be diluted before separation thereby compromising 
throughput and operation time. Another novel method to separate plasma from whole blood using 
bead-packed microchannels acting as filters has been demonstrated recently [Figure 1(B)] [20]. Blood 
introduced into the channel is driven by the capillary force induced by the bead column. As the RBCs 
movement is impeded by the packed beads, cell-free plasma is driven through the bead column. 
Without the use of microfilters, this technique minimizes RBCs clogging, but is unsuitable for rapid 
clinical diagnostics due to long separation time as a result of slow capillary action. 
In order to circumvent the aforementioned problems, several groups have investigated RBC 
depletion using flow through devices which function solely on inherent hydrodynamic separation 
mechanisms. Separating blood plasma based on the inherent hydrodynamic separation mechanisms 
frequently rely on the Zweifach-Fung effect, also known as bifurcation law [21-23]. The technique 
exploits the tendency of cells at branching points of microchannels to flow into the wider channel 
having a higher flow rate. By varying the channel widths of the daughter channels, Yang et al. reported 
a minimum flow rate ratio of 6:1 required between the main and smaller branching channels to obtain 
successful blood plasma separation [Figure 1(C)] [21]. The plasma selectivity obtained was close to 
100% and was independent of the inlet hematocrit levels while the collected plasma volume varied 
from 15 to 25% depending on the inlet hematocrit levels. Plasma separation from blood cells has also 
been achieved using “plasma skimming” or the Fahraeus effect. In microchannels flow under 
Poiseuille conditions, the highly deformable RBCs migrate towards the axial centre of the 
microchannels parallel to flow. This creates a lower cell concentration or “cell free” region near the 
channel walls where plasma can be extracted easily. Jaggi et al. demonstrated the use of a high-aspect 
ratio microchannel device with many vertical channel bifurcations arranged in parallel to extract 
plasma from blood [24]. The device permits very high throughput operating at relatively high flow 
rates of between 2 to 5 mL/min with high separation (cell depletion) efficiency (~90%) at 4.5% 
hematocrit. However, the cell depletion efficiency drops significantly to ~30% when tested with 
physiological hematocrit (45%). Blattert et al. combined centrifugal forces with plasma skimming to 
demonstrate plasma extraction using a simple microchannel bend [25,26]. The centrifugal forces 
results in differing settling velocities between the cells and plasma resulting in the collection of cell 
free plasma near the inner wall of the microchannel following the bend region. As this technique  
also relies on plasma skimming, blood dilution is necessary as a ~90% cell depletion efficiency at  
~5% hematocrit reduces to ~40% at 45% hematocrit. 
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Figure 1. Plasma separation from blood. (A) left: Schematic diagram shows the 
centrifugation based separation principle using an egg beater with the blood-filled PE 
tubing attached to the paddle (inset illustrates the photograph of a manual hand-powered 
egg beater). centre: Phase contrast images showing RBCs concentrations in the plasma 
layer and cell pellet region of the PE tubing after 10 min spinning. right: Graph showing the 
plasma volume generated against centrifugation time from a 100 µL blood sample. Reprinted 
with permission from [14] copyright 2008, The Royal Society of Chemistry; (B) left: 
Graphical illustration of plasma separation from whole blood using icrobeads-packed 
microchannel. As blood flows through the hydrophilic channel by capillary forces, RBCs 
movement is impeded by the packed beads while the plasma (yellow) continues to move 
forward. right: Photograph showing the formation of four separated regions as blood flows 
through the bead-packed channel corresponding to different stages of plasma separation. 
Figure reproduced from [20], copyright 2010, with kind permission from Springer  
Science + Business Media, LLC; (C) Plasma separation using hydrodynamics effects. left: 
Schematic representation of the Zweifach–Fung effect in which RBCs travel into the daughter 
channel with higher flow rate when the flow rate ratio is more than 2.5 times compared to the 
smaller daughter channel. The image at the bottom shows the schematic of the actual plasma 
separation device with the plasma separation region consisting of 5 bifurcated plasma 
skimming channels. centre: Photograph of the blood plasma separation region at a flow rate 
of 10 µL/h. right: Comparison between experimental and computational fluid dynamics 
(CFD) simulation results of the total plasma separation volume percent with respect to the 
upstream microchannel hematocrit level. The numbers indicate at each data point represent 
the inlet hematocrit levels. Redrawn with permission from [21], copyright 2006, The Royal 
Society of Chemistry. 
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Figure 2. (A) Plasma separation using acoustophoresis. Cross-sectional schematics of a 
microchannel excited by a λ/2 wavelength ultrasonic standing wave indicating the focusing 
of the RBCs at the channel center by the primary acoustic radiation force. By designing a 
multiple outlet system enriched blood cell fractions are removed from the center of the 
channel while clean plasma fraction can be withdrawn from the side. A transducer placed 
underneath the chip generates an ultrasonic standing wave between the channel walls 
perpendicular to the flow. Reprinted with permission from [27], copyright 2009, American 
Chemical Society; (B) Plasma separation using dielectrophoresis (DEP). The image shows 
the top and cross sectional views of plasma extraction principle from diluted blood (1:9) in 
the presence of electric field gradient. The strong DEP forces traps ~97% of RBCs at the 
electrodes extracting ~300 nL of plasma from 5 µL of blood. Figure reprinted from [33], 
copyright 2010, with permission from Elsevier; (C) left Schematic illustrating the principle 
of inducing swirling flows in microchambers by bulk electrohydrodynamics thrust or ionic 
winds generated by sharp corona electrode tip. right Successive time-lapse images 
indicating the concentration of RBCs near the bottom of the microfluidic chamber toward a 
stagnation point in a 0.4% hematocrit sample at 286 kV/m and 60 kHz field. Figure 
reproduced with permission from [31], copyright 2007, American Institute of Physics. 
 
Plasma separation techniques from blood using active energy sources such as acoustophoresis, 
electrohydrodynamics and dielectrophoresis have also been explored recently [27-33]. Acoustic forces 
generated by ultrasonic standing waves can be used for plasma separation in microchannels. The 
radiation force generated on the cells by these acoustic waves moves them into pressure nodes of the 
standing wave field. By exciting the microfluidic channel with half wavelength width ultrasonic wave, 
the cells/particles can be focused at the pressure node located at the center of the channel. Thus, 
pumping blood through the channels, the erythrocytes can be focused at the channel center and 
removed from the central outlet while the purified plasma can be continuously collected at the side outlets 
[Figure 2(A)] [27-29]. The device is capable of generating pure fractions of plasma (<6 × 106 cells/mL)  
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at ~80 μL/min flow rate. Dielectrophoresis (DEP) offers another effective method of separating blood 
plasma relying on an inhomogeneous electric field between two electrodes to induce electrostatic 
forces [Figure 2(B)] to trap cells. When polarizable cells (RBCs) are placed in the non-uniform electric 
field, a net electric force is imparted on the cells due to an induced or permanent dipole. Separation of 
blood plasma from diluted blood (1:9) using a DEP microfluidic device was demonstrated by 
Nakashima et al. [33]. Blood is injected into the main channel by capillary force and in the presence of 
an electric field the RBCs are trapped at the electrodes while cell free plasma is collected downstream. 
Applying an AC signal of 10 V and 10 MHz, the device is capable of removing about 97% of blood 
cells to generate 300 nL plasma from 5 μL of blood [33]. Recently, an interesting plasma separation 
technique based on creating swirling flows in a microfluidic chamber induced by bulk 
electrohydrodynamics thrust or ionic winds has been reported [Figure 2(C)] [30,31]. Applying a 
potential that exceeds the threshold ionization voltage for air across a mounted sharp corona electrode 
tip creates a nearly singular electric field giving rise to a corona discharge. The bulk 
electrohydrodynamic air thrust generated by the transfer of momentum from collision between the 
counter-ions with air molecules results in interfacial shear leading to recirculating flows [Figure 2(C)]. 
The cells suspended in the liquid are thus concentrated towards the bottom of the chamber by these 
inward radial forces. Using this technique, Yeo and co-workers successfully isolated plasma from 
RBCs within 200 s applying 0.94 kV voltage and 90 kHz frequency. The separation is efficient with 
the separated plasma consisting of <0.003% hematocrit cell contamination. 
3. Leukocyte Separation 
Leukocytes (or white blood cells (WBCs)) are the nucleated fraction of blood cells, mainly 
consisting of neutrophils, basophils, eosinophils, monocytes and lymphocytes, and are primarily 
responsible for all immunological functions. Compared to the vast abundance of erythrocytes  
(~5 million cells/μL), leukocytes are present at a much lower concentration, (typically between 4,000 
to 11,000 cells/μL) constituting ~0.1% of all blood cells. Isolation of leukocytes is essential for many 
hematological analysis and clinical diagnostic tests for monitoring disease progression [34]. Removal of 
leukocytes from blood, leukapheresis, is essential to reduce the white blood cell count in treating leukemic 
patients as well as to retrieve blood stem cells in patient with hematologic malignancies [35,36]. It is also 
essential to remove all leukocytes before performing a blood transfusion to minimize transmission of 
cell-associated infectious agents (cytomegalovirus, herpes virus, human T-cell lymphoma virus), graft 
rejection rates and prevent febrile transfusion reactions [37]. 
Traditionally, these cells are separated from blood by centrifugation exploiting the differences in the 
buoyant gravity by using a density gradient solution (Ficoll-Paque™). Besides density, leukocytes and 
RBCs are also structurally different both in terms of shape and size. Leukocytes are spherical 
nucleated cells with typical diameters ranging from 6 µm to 10 μm [38-40]. Red blood cells (RBCs) on 
the other hand have a biconcave disc-like structure with an average diameter of 7–8 µm and 2–3 µm 
thickness. Due to the high deformability of RBCs aided by the absence of nucleus, membrane-based 
filters are also commonly employed to filter leukocytes from blood [41,42]. The inherent differences in 
size and deformability between the RBCs and leukocytes have led to the development of several 
microfluidics techniques based on the principles of cell retention and retarded cell movement [40,43-45]. 
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The use of pillars in particular is an attractive technique for size and deformability based cell sorting in 
microfluidic devices. For example, Panaro et al. designed a silicon microchip with rectangular pillars 
spaced 3.5 µm to separate leukocytes from whole blood for subsequent PCR reactions [43]. The 
“deterministic lateral displacement” (DLD) or the “bump array” microdevice developed by Huang et al. 
has also been applied for blood fractionation [Figure 3(A)] [46,47]. The microfluidic device design 
consists of arrays of micro-pillar structures placed within the main flow channel leading to the 
formation of multiple cell streams based on size. Cells larger than the critical diameter dc = 20% × 2w 
(w is the separation gap between two adjacent pillars) follow a deterministic path while smaller cells 
remain unperturbed moving in an average downward flow direction. The bump array was successfully 
applied for fractionating blood components by tailoring the design to match the sizes of the blood cells. 
Apart from achieving 110-fold leukocyte enrichment, the device was capable of fractionating the 
individual WBC components. However, a processing flow rate of 1 µL/h results in an extremely low 
device throughput. 
A comprehensive study conducted by Ji and coworkers investigated the performance of four main 
types of silicon microfilter designs, namely, weir-based, membrane, pillars and cross-flow for efficient 
leukocyte trapping [44]. The critical dimension in all the four microfilter designs was fixed to 3.5 µm. 
Their results confirm the superiority of the pillars and cross-flow devices for leukocyte trapping with  
>60% of leukocytes trapped in the device. However, the cross-flow based device outperforms other filter 
designs in its blood handling capacity (>300 µL) and allowing >50% of RBCs to pass through. Similar 
cross-flow based leukocyte separation device have also been reported by other researchers. [40,45]. 
Sethu et al. developed a diffusive filter design consisting of a three parallel channels for leukocyte 
removal [Figure 3(B)] [40]. The two side channels are connected to the main channel through 2.5 µm 
deep microfabricated sieves. The sieves allow the passage of >50% deformable RBCs to the side 
channels while retaining >97% of the larger leukocytes in the center main channel at 5 µL/min 
throughput. Recently, VanDelinder and Groisman described a technique to separate cells by size and 
exchange carrier medium by perfusion in a continuous cross-flow based microfluidic device [45]. By 
designing 3 µm shallow connecting channels to impede leukocyte migration, the device retains >98% 
leukocytes in the center channel achieving a remarkably high enrichment factor of 4,000 fold by 
effectively depleting all RBCs. 
While all the aforementioned techniques effectively isolate leukocytes from blood, these techniques 
commonly suffer from clogging issues leading to shorter operational times and lower throughput. To 
address these limitations, novel separation techniques taking advantage of the emergent hydrodynamic 
behavior at the microscale have been developed. Hydrodynamic filtration methods relying on the 
relative position of the center of the cells in microchannels have been recently demonstrated for 
separating leukocytes from RBCs [Figure 4(A)] [48,49]. By designing multiple side branching 
channels, particles/cells of varying diameter can be aligned along the channel sidewalls and collected 
at different outlets downstream [48]. The device reports a ~29 fold leukocyte enrichment at a relatively 
high flow rate of 20 µL/min with no clogging. Similarly, the device developed by Zheng et al. takes 
advantage of the position of the leukocytes and RBCs along the flow streamlines to separate them in 
different outlets [49]. As the center of the leukocytes is further away from the channel sidewalls than 
the smaller RBCs, this allows the leukocytes to be extracted at outlets placed further downstream with 
a high separation efficiency of >97%. Another novel separation technique based on the principle of 
Micromachines 2011, 2                    
 
 
327
hydrophoresis has been reported for leukocyte isolation in microchannels patterned with slanted 
grooves on the top and bottom channel walls [50]. The hydrodynamic interaction of cells with a fluid 
flow induced by slant obstacles forces them to flow in different trajectories depending on the cell 
diameter. Using diluted blood (1:20), the device demonstrates a 210 fold leukocyte enrichment with  
85% recovery at a processing throughput of 4,000 cells/s. 
Figure 3. Leukocytes separation from blood. (A) left: Schematic of the fractionating 
device used for separating blood components based on deterministic lateral displacement 
(DLD) technique. centre Graphic illustrating the DLD separation principle together with 
histogram showing concentrations of different blood leukocyte components collected at the 
three outlets after separation. right: Experimental images showing the displacement of the 
bigger leukocytes (labeled with Hoechst 33342 dye) away from the inlet sample stream 
towards the right side of the channel by the bump array. Reprinted with permission  
from [47], copyright 2006 National Academy of Sciences, USA; (B) left: Schematic of the 
diffusive filter based microdevice for continuous flow fractionation of leukocytes from 
whole blood based on size and shape differences. The microchannel design consists of 
three parallel channels connected by 2.5 µm deep micro sieves. Blood pumped through the 
main channel center is depleted of RBCs at the side channels by cross-flow filtration while 
the bigger leukocytes are retained at the centre channel. right: Histogram showing the 
experimental fractionation results as a function of flow rate. At an optimal flow rate of  
5 µL/min >97% of leukocytes are collected from the center outlet with 50% RBC depletion. 
Redrawn with permission from [40], copyright 2006, The Royal Society of Chemistry. 
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Figure 4. (A) top: Leukocyte separation using hydrodynamic filtration. Schematic 
diagrams showing the particle position and trajectory at a branch point for low, medium, 
and high relative flow rates between the main and side channels. As liquid is continuously 
withdrawn from the side channels, all particles concentrate along the channel sidewalls and 
are separated into multiple side channels based on size. bottom: Microscopic images 
showing enrichment of leukocytes (indicated by arrows) before filtration (a) and at outlet 1 
and 3 after second filtration (b). Figure reproduced with permission from [48], copyright 
2005, The Royal Society of Chemistry; (B) Biomimetic leukocyte separation technique 
based on in vivo leukocyte margination phenomenon. top: The larger WBCs (red arrows) 
are displaced to the channel sidewalls due to axial migration of RBCs and extracted using 
an asymmetrically bifurcated outlet as shown. bottom: Histogram showing the leukocyte 
distribution at the end of a 5.5 mm long rectangular microchannel indicating the successful 
margination of all the leukocytes towards the channel side accomplishing a 34-fold 
enrichment. Figure redrawn with permission from [51], copyright 2005, American 
Chemical Society; (C) Affinity capture of leukocytes using patterned microstructures 
based on leukocyte recruitment and rolling. left: Illustration of different stages of cell 
adhesion in the square and offset micropillar array. As cells adhere on the lateral surface of 
the E selectin coated pillars (R), the fluid shear in the tangential direction make the cells 
roll along the pillars. Reaching the end of the pillars, these cells tend to tether and detach 
from the surface before being captured again by an adjacent pillar. Insets (red box) shows 
the microchannel image with square and offset arrays. centre: Images showing the 
accumulation of HL-60 cells captured along the square array at the start (top) and 2 min 
later (bottom). right: Graph showing the enrichment of HL-60 cells with time. HL-60 cells 
were enriched ~400 times in the square array and ~240 times in the offset array. Figure 
reprinted with kind permission from [53], copyright 2005, The Royal Society of Chemistry. 
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In vivo physiological phenomenon such as leukocyte margination and recruitment in the 
microcirculation has also been mimicked in microfluidic devices for leukocyte separation [51-53]. In 
blood vessels with luminal diameter less than 300 μm, RBCs due to their smaller size and higher 
deformability than the leukocytes, tend to migrate to the axial centre of the vessel under Poiseuille 
flow conditions. As these RBCs migrate towards the axial centre, mechanical collisions between the 
leukocytes and the migrating RBCs results in the displacement of the larger leukocytes towards the 
vessel wall; a phenomenon termed as margination [52,54]. This bio-mimetic phenomenon can be 
exploited to achieve ~34 fold leukocyte enrichment by designing appropriately branched daughter 
channels to continuously filter all the leukocytes present along the microchannel sidewalls from  
blood [Figure 4(B)] [51]. Recently, separation of leukemic HL-60 and U-937 cells based on the 
interaction between the cells and protein coated microchannel surfaces has also been demonstrated  
[Figure 4(C)] [53]. By coating pillar surfaces with E-selectin adhesion proteins to mimic in vivo 
phenomenon of leukocyte recruitment, the leukemic cells are immuno-captured and arrested from the 
passing flow. Due to the high selectivity, this technique permits the capture of >95% cells with  
150-fold average enrichment at a throughput of 15,000 cells/min. 
Most of the above mentioned techniques separate leukocytes based on their mechanical properties 
such as size and deformability. Besides taking advantage of the differences in these distinct mechanical 
properties to sort leukocytes from RBCs, the varying surface properties and net charges of these cells 
can also be used for efficient sorting as well. For example, SooHoo and Walker developed a novel 
method to separate leukocytes from whole blood using microfluidic aqueous two-phase system 
(ATPS) [Figure 5(A)] [55]. Using a three inlet system, polyethylene glycol (PEG) and dextran (Dex) 
solution are used to create one or two immiscible interfaces inside the microchannel. Blood diluted in 
PEG (1:50) is pumped through the center inlet, with dextran solutions pumped through the two side 
inlets. The PEG-Dex interface exhibits a force on the cells due to the ATPS interface surface energy. 
The magnitude of this force is proportional to the surface area and thus the leukocytes having a larger 
surface area experience higher force and prefer being at the interface while the RBCs migrate into the 
dextran solution. This simple separation method can process diluted blood at 1 µL/min flowrate with a 
~10 fold leukocyte enrichment with a two interface design [55]. Another interesting leukocyte 
recovery method taking advantage of the difference in lysing time between the leukocytes and RBCs 
when mixed in a hypotonic solution (de-ionized water) has been explored. When mixed with de-ionized 
water, RBC lysis completes within 8 s while leukocyte lysis begins after 3 s [56]. By designing a  
3-inlet microfluidic cassette (side inlets pump de-ionized water) integrated with a micromixer for 
efficient mixing and controlling the exposure time to within 10 s, all leukocytes are recovered along 
with the lysed RBC debris at the outlet [56]. 
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Figure 5. (A) left: Schematic illustration of leukocyte separation based on microfluidic 
aqueous two-phase system (ATPS). Whole blood diluted in PEG is exposed to either a one 
or two PEG-Dex interfaces, represented by the dashed line. Due to differences in surface 
energies, the leukocytes prefer the interface while RBCs migrate into the Dex region.  
right: Experimental images showing leukocyte separation from blood in one interface  
PEG-PEG-Dex system (a-b) and two interfaces Dex-PEG-Dex system (c-d). Figure 
reprinted from [55], copyright 2009, with permission from Springer Science + Business 
Media, LLC; (B) left: Schematic representation of lateral driven continuous dielectrophoretic 
separators using an (a) divergent and (b) convergent type interdigitated electrode pattern. 
right: Histograms showing the relative separation percentage of RBCs and WBCs at each 
outlet using the divergent (top) and convergent (bottom) type DEP microseparators. Figure 
reproduced with permission from [57], copyright 2008, The Royal Society of Chemistry;  
(C) top: Diagram showing various forces acting on a magnetically labeled cell passing over 
a magnetic stripe. By incubating blood with super paramagnetic CD45 microbeads, the 
flow trajectory of leukocytes can be altered by the magnetic stripes. bottom: Time lapse 
image showing a single tagged fluorescent leukocyte tracking along a magnetic stripe 
inclined at an angle of 9.6° to the fluid flow, indicated by white arrows. The RBCs in blood 
continue to remain in the sample stream and are unaffected by the magnetic force. Figure 
reproduced with permission from [58], copyright 2004, American Institute of Physics. 
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Leukocyte separation using active sorting techniques including dielectrophoresis and magnetic 
separation have been reported recently on the microscale. Han et al. developed lateral-driven 
dielectrophoretic (DEP) microseparators to isolate leukocytes from blood suspended in a highly 
conductive medium [Figure 5(B)] [57]. By subjecting the blood cells to a constant dielectrophoretic 
forces generated using patterned convergent and divergent type interdigitated microelectrodes, the 
leukocytes were separated from RBCs. As the RBCs have a higher density compared to leukocytes 
(RBCs ~ 1,130 kg.m−3, WBCs ~ 1,050–1,080 kg.m−3), the DEP force acting on them is higher 
resulting in a larger deflection at the electrodes. The authors report a 92% leukocyte recovery with ~7 
fold enrichment at a continuous flow rate of 50 µL/h. Finally, magnetic based leukocyte separation  
methods exploiting either inherent differences in the cells magnetic susceptibility or selectively 
immuno-labeling magnetic beads have been demonstrated [58-61]. For example, whole blood 
incubated with CD45 labeled super paramagnetic microbeads pumped through a microchannel with 
patterned magnetic stripes has been explored for leukocyte isolation [Figure 5(C)] [58]. As all 
leukocytes express CD45 surface markers to some degree, the magnetic stripes (magnetized by an 
externally applied field of 0.08T) alter the flow direction of the CD45 tagged leukocytes from 
unlabeled cells, thus achieving separation. Although, the selectivity of this technique is very high due 
to immuno-labeling, a significant portion (~50%) of leukocytes were lost either by being permanently 
stuck to the magnetic strips or were not sufficiently magnetized to alter their direction [59]. 
Additionally, magnetic bead sorting often requires pre-treatment of cells, which may damage cells 
inadvertently. To overcome this problem, separation of RBCs from leukocytes based on the inherent 
magnetic susceptibility of these cells has also been reported [60,61]. By patterning a ferromagnetic 
wire within a microchannel the wire concentrates and attracts the paramagnetic RBCs along its length 
while the diamagnetic leukocytes are separated in a continuous and efficient manner [61]. Using a 
three-stage cascaded system, the authors report a 97% leukocyte recovery with 15× enrichment at 
moderate flow rates of 2.5–20 µL/h [61]. 
4. Platelet Separation 
Platelets are the smallest type of cells found in blood (~2–3 µm diameter), and they are involved in 
many fundamental physiological processes such as hemostasis and thrombosis [62]. When bleeding 
from a wound occurs, circulating platelets adhere and aggregate at the injury site to initiate thrombus 
formation until the bleeding is stopped. Patients undergoing general surgery, organ transplants and 
trauma treatments frequently require platelet transfusion [63]. Platelets are usually extracted from 
blood via centrifugation and by other methods which include platelet-rich plasma preparation (PRP), 
the buffy-coat preparation (BC) and apheresis [64]. However, these techniques are inefficient because 
a significant portion of inactivated platelets are often lost either through high mechanical shear  
stress [65] or the purification process directly [64]. Thus new efforts in developing efficient platelets 
extraction are leveraging on existing low stress microfluidic technologies. 
Platelet separation in microfluidic systems has mainly been explored with active separation 
techniques using acoustophoresis [66] and dielectrophoresis [67]. Platelets can be separated  
into multiple fractions in a continuous mode via free flow acoustophoresis (FFA) [Figure 6(A)] [66].  
A half-wavelength acoustic standing wave generated between the microchannel side walls applies an 
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acoustic radiation force perpendicular to the direction of the flow. By using a combination of FFA and 
medium density manipulation, high separation efficiency can be achieved with 92% of the erythrocytes 
ending in the first fraction (center of the channel) while 99% of the platelets collected in the second. 
Similarly, by exploiting the fact that platelets are the smallest cells in blood and therefore experiences less 
dielectrophoretic force, dielectrophoresis can be used to extract high purity platelets (~95%) from diluted 
whole blood at a throughput of ~2.2 × 104 cells/s with minimal platelet activation [Figure 6(B)] [67]. 
Recently, single-step separation of individual platelets from whole blood by micropatterning of 
platelet-specific protein surfaces on solid substrates has been reported using an interfacial platelet 
cytometry (iPC) chip [62]. Platelets were separated from whole blood using iPC coated with 
fibrinogen, von Willebrand factor (VWF), and anti-CD42b antibody printed “spots” ranging from 2–24 μm 
diameter. The paper reports on tests conducted with blood samples from healthy donors and a 
Glanzmann’s Thrombasthenia patient. As the platelets are allowed to adhere to the surface, the iPC 
chip enables physiologically relevant platelet bioassays based on platelet/protein-matrix interactions. 
Figure 6. Platelets separation from blood. (A) top: Illustration of free flow acoustophoresis 
(FFA) showing size-based separation of particles or cells into multiple fractions in a 
continuous flow manner. The varying acoustic forces equilibrate the larger cells closer to 
the channel center and smaller cells farther from the center. bottom: The fractionated 
particles can be collected separately by designing five consecutive outlets/fractions. The 
histogram shows the separation of platelets, RBCs and leukocytes at the various outlets 
indicating majority of platelets collected at outlet 4. Reprinted with kind permission from [66], 
copyright 2007, American Chemical Society; (B) top: Device architecture of the two-stage 
DEP-activated cell sorter (DACS) chip. The integration of two tandem purification stages 
increases the purity of the platelet population at the collection outlet. bottom: Schematic 
illustration of the DEP separation principle indicating the forces acting on the blood cells. 
The larger blood cells experience a higher DEP force from the electrodes and are deflected 
from the side to the central buffer stream while the smaller platelets are a retained in the 
side buffer stream. Figure adapted with permission from [67]. copyright 2008 Wiley-VCH 
Verlag GmbH and Co. KGaA. 
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5. Rare-Cell Separation 
Besides blood constituents, other cells of interest such as circulating tumor cells (CTCs), nucleated 
RBCs (nRBCs) and microorganisms are also present in peripheral blood, which are of clinical 
significance and important for disease diagnosis and fundamental research. As these cells usually occur 
in low abundance (~1–10,000 cells/ mL of blood (~109 RBCs)), common macroscale separation techniques 
such as physical filtration, fluorescence-activated cell sorting (FACS) and magnetically-actuated cell 
sorting (MACS) have limited success in separating/isolating them mainly due to laborious sample 
preparations which introduce artifacts or lead to loss of desired cells [68]. Moreover, mechanical 
stress-induced changes in original cell phenotype using these techniques have also been reported, 
suggesting the need to develop new tools for separating these rare cells [69,70]. Microfluidic based 
separation methods are an attractive alternative due to the small length scale and numerous advantages 
such as reduced sample and reagent volumes, minimize contamination issues and process  
automation [4,34]. These inherent advantages also make microfluidics ideal in resource-poor settings 
where problems such as shortage of power supply and refrigeration are limiting the use of expensive 
and specialized equipment. For example, several microfluidic devices have been developed for malaria 
detection, which is one of the severest parasitic blood-borne diseases and most prevalent in the poorer 
countries. The separation principles are mostly based on intrinsic properties of malaria-infected RBCs 
(iRBCs) such as dielectric differences [71], paramagnetic affinity [72], and change in stiffness [73,74] 
to separate or enrich them from blood for diagnostic applications. However, as iRBCs constitute 
~0.01–1% in peripheral blood of malaria patients, they are not considered as rare-cell per se and thus 
excluded in our discussion. In this section, separation of various types of rare cells from blood using 
microfluidics will be presented. 
5.1. Nucleated RBCs 
Prenatal diagnosis for genetic abnormalities in fetus is usually performed by collecting fetal 
samples through amniocentesis and chorionic villus sampling (CVS), which are invasive procedures 
and puts the patient at risk of miscarriage. While ultrasonography and serum biochemistry testing are 
currently used to screen patients for non invasive prenatal diagnosis, it has been reported fetal 
nucleated RBCs (nRBCs) present in maternal circulation can be used for direct analysis of fetal 
chromosomes and their enumeration is also associated with fetal aneuploidies or pregnancy 
complications [75,76]. In addition, nRBCs have short life span and are unlikely to persist between 
pregnancies, making them a suitable candidate for direct fetal karyotype analysis. As nRBCs are 
extremely rare (~1–30 nRBCs/mL of blood), enrichment or isolation of these cells usually consists of 
density gradient centrifugation to obtain the mononuclear cells, followed by immuno-labeling and 
FACS or MACS selection. These procedures are time consuming, labor-intensive and leads to 
significant loss of nRBCs. 
Several microfluidics devices have been developed to isolate these nRBCs using intrinsic markers 
such as size and deformability, and hemoglobin content. The nRBCs are around 9–12 µm and similar 
in size with leukocytes (10–15 µm), but larger than bulk of the RBCs (~6–8 µm in diameter). 
Mohamed et al. have developed a simple microdevice which consists of an array of micropillars of 
Micromachines 2011, 2                    
 
 
334
different gap sizes (2.5 to 15 µm) to separate the fetal nRBCs from blood based on size and 
deformability [Figure 7(A)] [77]. Using mononuclear cells as their sample, they demonstrated that all 
the leukocytes were trapped at the 2.5 µm width gaps while nRBCs deformed through the entire device 
and were collected for subsequent DNA analysis. No immunolabeling was required in this process but 
sample preparation including sample dilution and ficoll centrifugation were used to obtain the 
mononuclear layer. The device throughput was also considerably low (~0.35 mL/h) taking ~6–8 h to 
process each sample. To improve the throughput, Lee et al. have recently developed a microfluidic 
device which continuously separates nRBCs from RBCs based on cross-flow filtration [78]. In this 
system, sample and buffer solutions were pumped into the bottom and upper inlet respectively. Smaller 
RBCs were filtered through the inclined filter of 4 µm gap and collected at the bottom outlet (port 4). 
The bigger nRBCs, which could not deform through, would roll along the filter and be diverted 
upstream into the upper outlet (port 3), thus achieving separation. Throughput was higher in this device 
(0.3 mL/min) with good nRBCs recovery (74%), while 46.5% of RBCs were depleted in the upper 
outlet (~1.7 fold enrichment). However, a major limitation was the absence of whole blood testing, in 
which the bigger and stiffer leukocytes would probably clog the filters or be diverted upstream, resulting 
in lower nRBCs purity. Moreover, in both aforementioned methods, only dilute blood samples could be 
used as RBCs clog the filters easily which would affect the separation efficiency of nRBCs. 
Recently, Huang et al. developed a 2-step microfluidic based isolation technique for nRBCs using 
the popular ‘deterministic lateral displacement’ phenomenon [79]. In the first step, using the bump 
array microchip, the larger leukocytes and nRBCs were separated from the RBCs and platelets. Post 
sorting, the mononuclear cells (nRBCs and leukocytes) were treated with sodium nitrite to convert the 
hemoglobin present in nRBCs to methemoglobin which is paramagnetic in nature allowing the 
isolation of nRBCs using a magnetic column. This microfluidic-magnetic combination method was 
able to eliminate 99.99% RBCs and leukocytes with 100% nRBCs identification in 58 predetermined 
samples [79]. Throughput was also higher in this device (~2.5 mL/h) and whole blood was used 
directly without sample dilution. Further work will be necessary to integrate both processes into a 
single device to improve nRBCs isolation from blood for non invasive prenatal diagnosis. 
5.2. Circulating Tumor Cells 
Circulating tumor cells (CTCs) in blood is an important intermediate step in cancer metastasis, 
which accounts for ~90% of all cancer related deaths [80]. Clinical studies have shown that 
enumeration of CTCs can be correlated with cancer progression [81,82] and this “liquid biopsy” is 
more practical as they can be performed more frequently than traditional invasive biopsies to predict 
prognosis and guide therapy in cancer patients [83,84]. For CTCs enumeration to be useful in clinical 
management of cancer, a highly efficient and robust CTC separation tool is required due to the low 
abundance of these CTCs in blood. In the past decade, several microfluidics platforms have been 
developed for CTCs separation from blood based on either physical filtration or affinity capture. 
Due to the large size differences between CTCs and other blood cellular components (CTCs ~16–20 µm; 
RBC ~8 µm; leukocytes ~10–15 µm) [85,86], size-based CTCs separation in microfluidic devices is 
often achieved using microstructures of different geometries to physically trap the larger CTCs [87-90]. 
The critical dimension in these devices is the size of the pore/structure which is designed to allow 
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maximum CTCs trapping with little contamination. Using gap sizes between 5 to 10 µm, these 
microfluidic devices are able to demonstrate isolation of cancer cells with high efficiency (>80%), but 
the isolation purity varies greatly due to trapping of the bigger leukocytes [87-89]. The trapped CTCs 
usually deforms at the pores under constant shear during sample processing, making their retrieval 
difficult and thus requiring post-sorting analysis to be done on chip. To address this problem, Tan et al. 
used an array of crescent-shaped isolation traps to isolate the CTCs in a more gentle manner which 
allowed subsequent retrieval out of chip for downstream analysis [Figure 7(B)] [90]. The separation 
principle is simple, does not require the use of biomarkers like EpCAM anti-bodies and allow the 
retrieval of viable CTCs for further molecular characterization and analysis. 
Apart from physical filtration methods, affinity based capture of CTCs in microfluidic devices 
either by immobilizing specific capture molecules on magnetic beads [91], microstructures [92,93], or 
array of channels [94] has been a popular CTC isolation approach. Using an array of anti EpCAM-coated 
microposts, Nagrath et al. demonstrated that they were able to isolate CTCs from peripheral blood in 
115 out of 116 (~99%) cancer patients in a single step [Figure 7(C)] [93]. However, a major drawback 
for affinity capture is difficulty in finding ligands that have high specificity and affinity for CTCs due 
to their heterogeneity in surface molecular signatures. The use of common epithelial markers such as 
EpCAM is less desirable as EpCAM expression varies widely for different or even same tumor  
type [95] and retrieval of isolated CTCs may be difficult due to cell binding in the devices. Moreover, 
there is a risk of losing the most aggressive CTCs subpopulation due to epithelial to mesenchymal 
transition (EMT) process, which leads to a down-regulation of epithelial surface markers and thus the 
inability for CTCs to bind efficiently [96,97]. Recently, it has been demonstrated that aptamers  
(single-stranded nucleic acid oligomers) could be used as probes to isolate CTCs with high affinity and 
specificity [98,99]. As aptamers are synthesized by an in vitro process known as cell-SELEX 
(Systematic Evolution of Ligands by EXponential enrichment), the surface molecular information of 
CTCs are not required and different aptamer probes can be generated for any type or subpopulation of 
CTCs. Whole blood can be used directly without dilution for affinity capture, but throughput is still 
slow due to low shear rates to allow sufficient time for the CTCs to bind to capture surfaces as well as 
to prevent bound CTCs from being detached under high shear. 
5.3. Microorganisms 
Separation of microorganisms from blood is primarily used as a therapeutic blood cleansing method 
for treating sepsis, a lethal disease caused by a systemic microbial infection that spreads via the 
bloodstream and compromise the body’s immunological system [100]. Antibiotics are often the main 
course of treatment, but inflammation continues to spread for a few hours before the drugs are 
effective. For newborn infants with sepsis (neonatal sepsis), their immune system are still functionally 
immature and delay or inappropriate antibiotic treatment may cause fatality [101]. In this section we 
will review several microfluidic technologies which have been developed to separate microorganisms 
and pathogens from blood for potential sepsis treatment. 
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Figure 7. Rare cells separation from blood using microfluidics. (A) Schematic of the cross 
flow filtration principle for nRBCs separation. RBCs are continuously filtered out through 
the inclined filters with a 4 µm gap while the bigger nRBCs cannot deform through the 
filters and are made to roll along the filter upstream and collected separately. Figure 
reprinted from [78], copyright 2010, with kind permission from Elsevier; (B) Schematic 
design of a microfluidic device for CTCs isolation and enumeration. Placing crescent-shaped 
cell traps in the isolation regions traps the larger tumor cells while allowing smaller blood 
components to sieve through. Figure reproduced from [90], copyright 2009, with 
permission from Springer Science + Business Media, LLC; (C) Layout of the CTC chip 
designed by Nagrath et al. consisting of functionalised micropost array for affinity capture 
of CTCs. Inset showing a scanning electron micrograph of a lung cancer cell captured 
between two microposts. Reprinted with permission from Macmillan Publishers Ltd: 
Nature [93], copyright 2007; (D) Schematic illustrating the separation principle using a 
micromagnetic-microfluidic based blood cleansing device to selectively remove pathogens 
from contaminated blood. Immunomagnetic microbeads bind selectively to the pathogens 
(see inset) to create magnetic opsonins which are removed continuously in the presence of 
magnetic field gradients. Figure adapted with permission from [105], copyright 2009, The 
Royal Society of Chemistry. 
 
 
Typically microorganisms are very small ranging from 1 to 3 µm in diameter and thus can be easily 
separated from the larger RBCs and leukocytes. Wu et al. separated bacteria from blood using inertial 
lift force-induced migration based on size difference between bacteria and blood cells [102]. The 
technique relies on the lateral displacement of the larger RBCs due to stronger wall-induced inertial lift 
forces while the bacteria would remain in sample stream. The authors demonstrated removal of  
~60% bacteria from a 10% (v/v) blood samples at a flow rate of 18 µL/min. Using similar inertial 
focusing principle, Mach et al. developed a high throughput blood filtration device which consists of 
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40 high-aspect-ratio channels in parallel that can filter out bacteria from diluted blood sample  
(0.5% hematocrit) at 8 mL/min continuously [103]. As inertial separation relies entirely on intrinsic 
hydrodynamic forces, the design and device fabrication of these devices is simple and the large 
channel dimensions also eliminate problems of channel clogging [4]. However, cell–cell interactions 
can deteriorate the efficiency of this separation technique whereby only dilute samples can be used, 
thus requiring additional sample preparation procedures. 
Recently micromagnetic based microfluidic blood cleansing have been developed by Xia and  
co-workers. The design consists of a microfluidic “H-filter” for continuous separation of E-coli from 
blood using magnetic nanoparticles specifically bound to bacteria [Figure 7(D)] [104]. By fabricating a 
magnetic (NiFe) microcomb structure adjacent to the channel, a steep magnetic field gradient can be 
generated across the flow channel when magnetised externally allowing the opsonized bacteria to be 
deflected from the original flow path and collected separately. The group demonstrated a throughput of 
~104 cells/sec (at flow rates of 25 µL/h) with bacteria separation efficiency of ~78% using whole blood 
sample spiked with E coli. The group later improved the design using an array of channels and 
demonstrated fungal separation from whole blood with 1000× higher throughput (~20 mL/h) [105]. 
This method is highly versatile and can be used to separate multiple types of infectious microorganisms 
simultaneously by using appropriately labeled magnetic beads. However, one would require prior 
information on the pathogens to select the binding molecules for coating of magnetic beads. 
6. Conclusions and Outlook 
Here, we highlight the development of several microfluidic approaches that exploit the different 
physical characteristics of cells, fluid mechanics and biorheology of blood as well as the difference in 
binding affinity of specific targeted cells to separate and/or enrich them. These include red cells, 
leukocytes, platelets, rare cells (such as CTCs) and pathogens (such as bacteria).  
We envisage that we will continue to push the boundary of this research as more creative and 
innovative methods continue to be developed and introduced in the near future. It is likely that they 
will cater not only for the processing of both large and small volumes of blood, but are also fast and 
efficient and with high sensitivity, purity and yield. However, for these blood-based separation systems 
to be realized as true point-of-care (POC) devices, these techniques and devices must be simple, easy 
to use and with little or no sample preparation required. This will set the challenges for researchers 
working on POC devices and will by no means be easy, but possible. 
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